Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Dingledine

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Neurobiology of Disease|January 21, 2015
Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticusJianxiong Jiang, Myung-Soon Yang, Yi Quan, et al.
Journal of Neuroinflammation|November 21, 2021
Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's diseaseAvijit Banik, Radhika Amaradhi, Daniel Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2013
Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammationJianxiong Jiang, Yi Quan, Thota Ganesh, et al.
Epilepsia|January 23, 2014
Cyclooxygenase-2 in epilepsyAsheebo Rojas, Jianxiong Jiang, Thota Ganesh, et al.
The Journal of Physiology|October 30, 2004
Metabotropic glutamate receptors modulate feedback inhibition in a developmentally regulated manner in rat dentate gyrusJames J Doherty, Sudar Alagarsamy, Kristopher J Bough, et al.
Journal of Biomolecular Screening|October 19, 2007
High-throughput screening fluorescence polarization assay for tumor-specific Hsp90Yuhong Du, Kamalika Moulick, Anna Rodina, et al.
Epilepsia|June 5, 2008
Characterization of osteopontin expression and function after status epilepticusKarin Borges, Marla Gearing, Susan Rittling, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2022
Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal modelsVarun Rawat, Avijit Banik, Radhika Amaradhi, et al.
Epilepsy Research|April 10, 2007
Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic dietKristopher J Bough, Maryse Paquet, Jean-François Paré, et al.
Journal of Neurochemistry|February 25, 2015
Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitroBjørnar Hassel, Ahmed Elsais, Anne-Sofie Frøland, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Neurobiology of Disease|January 21, 2015
Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticusJianxiong Jiang, Myung-Soon Yang, Yi Quan, et al.
Journal of Neuroinflammation|November 21, 2021
Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's diseaseAvijit Banik, Radhika Amaradhi, Daniel Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2013
Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammationJianxiong Jiang, Yi Quan, Thota Ganesh, et al.
Epilepsia|January 23, 2014
Cyclooxygenase-2 in epilepsyAsheebo Rojas, Jianxiong Jiang, Thota Ganesh, et al.
The Journal of Physiology|October 30, 2004
Metabotropic glutamate receptors modulate feedback inhibition in a developmentally regulated manner in rat dentate gyrusJames J Doherty, Sudar Alagarsamy, Kristopher J Bough, et al.
Journal of Biomolecular Screening|October 19, 2007
High-throughput screening fluorescence polarization assay for tumor-specific Hsp90Yuhong Du, Kamalika Moulick, Anna Rodina, et al.
Epilepsia|June 5, 2008
Characterization of osteopontin expression and function after status epilepticusKarin Borges, Marla Gearing, Susan Rittling, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 29, 2022
Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal modelsVarun Rawat, Avijit Banik, Radhika Amaradhi, et al.
Epilepsy Research|April 10, 2007
Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic dietKristopher J Bough, Maryse Paquet, Jean-François Paré, et al.
Journal of Neurochemistry|February 25, 2015
Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitroBjørnar Hassel, Ahmed Elsais, Anne-Sofie Frøland, et al.
Pageof 8